These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 9405911
1. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Fiehn W, Ziegler R, Wahl P, Nawroth PP. Diabetes Care; 1997 Dec; 20(12):1880-6. PubMed ID: 9405911 [Abstract] [Full Text] [Related]
2. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Schmidt AM, Fiehn W, Ziegler R, Wahl P, Nawroth PP. Diabetes Care; 1998 May; 21(5):841-8. PubMed ID: 9589252 [Abstract] [Full Text] [Related]
3. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Böger RH, Bode-Böger SM, Sydow K, Heistad DD, Lentz SR. Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872 [Abstract] [Full Text] [Related]
4. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease. Manns BJ, Burgess ED, Hyndman ME, Parsons HG, Schaefer JP, Scott-Douglas NW. Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348 [Abstract] [Full Text] [Related]
5. Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link? Kunz K, Petitjean P, Lisri M, Chantrel F, Koehl C, Wiesel ML, Cazenave JP, Moulin B, Hannedouche TP. Nephrol Dial Transplant; 1999 Aug; 14(8):1934-42. PubMed ID: 10462274 [Abstract] [Full Text] [Related]
6. Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine. Ducloux D, Fournier V, Rebibou JM, Bresson-Vautrin C, Gibey R, Chalopin JM. Clin Nephrol; 1998 Apr; 49(4):232-5. PubMed ID: 9582553 [Abstract] [Full Text] [Related]
7. Hyperhomocyst(e)inemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives. Beaumont V, Malinow MR, Sexton G, Wilson D, Lemort N, Upson B, Beaumont JL. Atherosclerosis; 1992 Jun; 94(2-3):147-52. PubMed ID: 1632868 [Abstract] [Full Text] [Related]
8. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction. Stühlinger MC, Stanger O. Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202 [Abstract] [Full Text] [Related]
9. Fasting and post-methionine load homocyst(e)ine values are correlated with microalbuminuria and could contribute to worsening vascular damage in non-insulin-dependent diabetes mellitus patients. Lanfredini M, Fiorina P, Peca MG, Veronelli A, Mello A, Astorri E, Dall'Aglio P, Craveri A. Metabolism; 1998 Aug; 47(8):915-21. PubMed ID: 9711985 [Abstract] [Full Text] [Related]
10. Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys. Lentz SR, Malinow MR, Piegors DJ, Bhopatkar-Teredesai M, Faraci FM, Heistad DD. Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2930-4. PubMed ID: 9409278 [Abstract] [Full Text] [Related]
11. [Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options]. Sydow K, Böger RH. Z Kardiol; 2001 Jan; 90(1):1-11. PubMed ID: 11220081 [Abstract] [Full Text] [Related]
12. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study. Langman LJ, Ray JG, Evrovski J, Yeo E, Cole DE. Arch Intern Med; 2000 Apr 10; 160(7):961-4. PubMed ID: 10761961 [Abstract] [Full Text] [Related]
13. Determinants of plasma homocyst(e)ine in patients with nephrotic syndrome. Joven J, Arcelús R, Camps J, Ordóñez-Llanos J, Vilella E, González-Sastre F, Blanco-Vaca F. J Mol Med (Berl); 2000 Apr 10; 78(3):147-54. PubMed ID: 10868477 [Abstract] [Full Text] [Related]
14. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion. Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Semmelrock J, Haas A. Graefes Arch Clin Exp Ophthalmol; 2002 Apr 10; 240(4):286-90. PubMed ID: 11981642 [Abstract] [Full Text] [Related]
16. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. Yoo JH, Chung CS, Kang SS. Stroke; 1998 Dec 01; 29(12):2478-83. PubMed ID: 9836754 [Abstract] [Full Text] [Related]
17. Hyperhomocyst(e)inemia induces multiorgan damage. Miller A, Mujumdar V, Shek E, Guillot J, Angelo M, Palmer L, Tyagi SC. Heart Vessels; 2000 Dec 01; 15(3):135-43. PubMed ID: 11289502 [Abstract] [Full Text] [Related]
18. Prevalence of familial hyperhomocyst(e)inemia in men with premature coronary artery disease. Genest JJ, McNamara JR, Upson B, Salem DN, Ordovas JM, Schaefer EJ, Malinow MR. Arterioscler Thromb; 1991 Dec 01; 11(5):1129-36. PubMed ID: 1911700 [Abstract] [Full Text] [Related]
19. Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis. Lee YK, Kwon YJ, Yoon JW, Oh KS, Cha DR, Cho WY, Huh K, Pyo HJ, Kim HK. J Korean Med Sci; 1999 Apr 01; 14(2):193-8. PubMed ID: 10331567 [Abstract] [Full Text] [Related]